Livongo Announces New Device, Medication, And Data Capabilities To Support New Applied Health Signals™ Category

MOUNTAIN VIEW, Calif., Oct. 30, 2018 /PRNewswire/ -- Livongo, the first company to apply health signals to empower people with chronic conditions to live better and healthier lives, today announced the first voice-enabled, at-home, cellular blood pressure monitoring system, free medication incentives for eligible members, and a number of new data science capabilities and partnerships. These innovations support the company’s introduction of Applied Health Signals, a new category of technologies and capabilities that for the first time combines data science, behavior enablement, and clinical impact to help make it easier for people with chronic conditions to stay healthy.

“It’s exciting to introduce products that change the way people think about and experience chronic conditions. We did that in diabetes, with unlimited free strips, cellular-connected meters, insights, and care accessible 24 hours a day anywhere, all of which made it easier for our members to stay healthy. Now we’re doing the same thing for hypertension,” said Amar Kendale, Livongo’s Chief Product Officer. “By delivering blood pressure feedback in a new relevant way and by driving positive behavior change with medication incentives, we are reducing the confusion, complexity, and cost of healthcare for our members. We are making healthcare less noisy and paving the way for meaningful and measurable change. That’s what Applied Health Signals is all about.”

Health signals are created by an individual’s behaviors, health status, lifestyle, and preferences. These signals can guide individuals and their care providers to proactively make changes to optimize clinical outcomes. Too often, people living with chronic conditions are presented with too many health data points to take meaningful action. Livongo quiets the noise by aggregating, interpreting, applying, and iterating (AI+AI^TM) health signals to make healthy behaviors more accessible.

The new product offerings and partnerships, which harness the power of Applied Health Signals and enable AI+AI, include:

• The first voice-enabled cellular blood pressure monitoring system. This enhancement builds on Livongo’s previously announced cellular blood pressure monitoring system, which allows members to instantly and effortlessly upload readings to the Livongo cloud (Cuff to Cloud^TM). This next generation system will allow a user to easily interact with Livongo via voice at each check. The innovation enables a whole new way to deliver actionable, personalized, and timely health signals that can lead to behavior change and clinical outcomes.
  
• A behavior-driven incentives program that makes medication free. Eligible Livongo members receive co-pay waivers on medications making their medications free. This innovation overcomes the critical access barrier of cost and leverages personalized data insights to motivate the healthy behaviors that can lead to clinical outcomes.
  
• Data Partnerships. Livongo is bringing key partners to research data sets and uncover new outcome-focused health signals that will improve the Livongo Applied Health Signals Engine over time. Livongo previously announced a research collaboration with Eli Lilly and Company to combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care, and an agreement with Abbott to integrate continuous glucose data from Abbott’s FreeStyle^® Libre Pro System. Today, Livongo announced a partnership with Medisafe that will improve medication management for people with chronic conditions and further its data and capabilities in the Applied Health Signals category.

“I could not be more excited to be working with industry leaders and innovators like Lilly, Abbott, and Medisafe,” said Livongo’s Chief Medical Officer Dr. Jennifer Schneider M.D., M.S. “These partnerships will provide a wealth of new data into our Applied Health Signals engine, and will further our ability to apply actionable, personalized, and timely health signals to our members. We are already achieving measurable clinical outcomes, and as more data comes into our engine, our fly wheel begins to spin faster, and we have the ability to affect more behavior change and improve clinical outcomes for more people with chronic conditions.”

Livongo’s voice-enabled blood pressure system and co-pay incentive programs will be made available to members in 2019. For more information on Applied Health Signals and Livongo, visit www.livongo.com.

About Livongo
Livongo pioneered the category of Applied Health Signals™ to empower people with chronic conditions to live better and healthier lives. Livongo’s team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized, and timely health signals. Livongo is the first company at the intersection of data science, behavior enablement, and clinical impact with the technologies and capabilities to silence Noisy Healthcare™. Our approach is leading to better clinical and financial outcomes while creating a better experience for people with chronic conditions. For more information, visit: www.livongo.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/livongo-announces-new-device-medication-and-data-capabilities-to-support-new-applied-health-signals-category-300739990.html

SOURCE Livongo Health